Canada’s National Advisory Committee on Immunization (NACI) recommends vaccinating key populations, such as people at risk of severe illness or
Continue reading »
Low risk of cancer spread on active surveillance for early prostate cancer
Men undergoing active surveillance for prostate cancer have very low rates – one percent or less—of cancer spread (metastases) or
Continue reading »
FDA Approves Expanded Indication for Merck’s Keytruda (pembrolizumab) in Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (cHL)
KENILWORTH, N.J.–(BUSINESS WIRE) October 15, 2020 — Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced
Continue reading »
Bevacizumab Less Effective for Diabetic Macular Edema in Blacks
WEDNESDAY, Oct. 28, 2020 — Black patients with diabetic macular edema are significantly less likely to show short-term visual improvement
Continue reading »
Superior outcomes for acute myeloid leukemia patients in clinical trial
Patients participating in The Leukemia & Lymphoma Society’s (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes
Continue reading »
Weight-reduction surgery for severely obese adults may prevent second heart attack, death
People with severe obesity (BMI >35) and a prior heart attack who undergo weight-reduction surgery may lower their risk of
Continue reading »
Tracer molecule may improve imaging tests for brain injury
Researchers have validated a new radiolabeled molecule that can be used with imaging tests to accurately detect and characterize brain
Continue reading »
Axillary surgery may not be necessary for all women with invasive breast cancer
More women could potentially be spared an axillary lymph node dissection—the surgical removal of 10-20 lymph nodes—a procedure that causes
Continue reading »
Details about broadly neutralizing antibodies provide insights for universal flu vaccine
New research from an immunology team at the University of Chicago may shed light on the challenges of developing a
Continue reading »
Anti-siglec-8 antibody trial shows promise for treating eosinophilic gastritis and duodenitis
Eosinophilic gastritis and duodenitis are inflammatory diseases characterized by high levels of eosinophils and mast cells (immune system cells) in
Continue reading »